Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities

June 9, 2021

Supplements and Featured Publications, Understanding Autoimmunity in Type 1 Diabetes and Potential for Therapeutic Opportunities,

Although type 1 diabetes (T1D) includes a reasonably small patient population, it does impose a significant impact on patients, caregivers, payers, and society. This piece explores the history; physical, economic, and psychosocial burden; and clinical pathophysiology of T1D to evaluate opportunities for earlier intervention to change the standard of care for this disease and improve overall outcomes.